Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Plasma Neprilysin for Early Prediction of Sepsis Within 48 Hours in ICU Patients With Infection or Suspected Infection (NEPSIS): A Multicenter Prospective Cohort Study

NCT07796386 is registered in ClinicalTrials.gov with Zhujiang Hospital as lead sponsor.

NCT NCT07796386
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07796386 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Plasma Neprilysin for Early Prediction of Sepsis Within 48 Hours in ICU Patients With Infection or Suspected Infection (NEPSIS): A Multicenter Prospective Cohort Study
Lead sponsor
Zhujiang Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
August 1, 2026
Completion date
April 30, 2028
Enrollment
488 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

infection, sepsis